Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Oncogene. 2015 May 18;35(7):919–928. doi: 10.1038/onc.2015.146

Figure 5. MALT1 controls NF-κB and STAT3 activation in EGFR-driven lung cancer model.

Figure 5

(a) Representative IHC staining of lung sections from tetO-EGFRL858R; CCSP-rtTA; MALT1+/− and tetO-EGFRL858R; CCSP-rtTA; MALT1−/− mice by using indicated antibodies. (b) The intensity × percentage of positive signals in (a) were compared for each staining. 10–15 random fields were chosen for each genotype, and were repeated three times using different mice (n=3) for each genotype.